APA (7th ed.) Citation

LJ, W., JP, A., S, A., TJ, E., G, M., K, M., . . . PM, B. (2023). Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): Effects on outcomes at day 365 in a randomised, sham-controlled, blinded, phase III, superiority ambulance-based trial. BMJ neurology open, 5(1), e000424. https://doi.org/10.1136/bmjno-2023-000424

Chicago Style (17th ed.) Citation

LJ, Woodhouse, et al. "Prehospital Transdermal Glyceryl Trinitrate in Patients with Ultra-acute Presumed Stroke (RIGHT-2): Effects on Outcomes at Day 365 in a Randomised, Sham-controlled, Blinded, Phase III, Superiority Ambulance-based Trial." BMJ Neurology Open 5, no. 1 (2023): e000424. https://doi.org/10.1136/bmjno-2023-000424.

MLA (9th ed.) Citation

LJ, Woodhouse, et al. "Prehospital Transdermal Glyceryl Trinitrate in Patients with Ultra-acute Presumed Stroke (RIGHT-2): Effects on Outcomes at Day 365 in a Randomised, Sham-controlled, Blinded, Phase III, Superiority Ambulance-based Trial." BMJ Neurology Open, vol. 5, no. 1, 2023, p. e000424, https://doi.org/10.1136/bmjno-2023-000424.